The US Food and Drug Administration (FDA) has given an emergency use authorization to the first commercial laboratory test to detect neutralizing antibodies against SARS-CoV-2, the virus that causes ...
In a recent study published in Science Advances, a group of researchers evaluated the feasibility and benefits of lateral flow assay (LFA)-based antibody tests for detecting inadequate coronavirus ...
(Reuters) - LabCorp said on Thursday it has launched a new test that could assess the capacity of antibodies in patient plasma to inhibit the novel coronavirus. Information from the test about the ...
WASHINGTON, D.C. — More than 50 million people in the country are now fully vaccinated against COVID-19. "Most of America is already speeding towards normalcy," said former Baltimore Health ...
A monoclonal antibody appears effective at neutralizing the numerous variants of SARS-CoV-2, as well as related viruses in animals that could pose a threat if they were to begin spreading in people.
The LP.8.1-adapted BNT162b2 COVID-19 vaccine elicited a strong immune response and showed an acceptable safety profile in ...
As more people get over COVID-19, they have immunity. Considering there may have been cases in the U.S. since December or January, that means plenty of people now cannot get sick from the virus. And ...
BOSTON & TORONTO--(BUSINESS WIRE)--Virna Therapeutics announces that they are partnering with University of Toronto to in-license neutralizing antibodies, to treat COVID-19. The discovery was made in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results